Sonpavde G - Search Results

1

Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.

Pond GR, Armstrong AJ, Wood BA, Brookes M, Leopold L, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Sonpavde G. Pond GR, et al. Among authors: sonpavde g. Eur Urol. 2012 Feb;61(2):363-9. doi: 10.1016/j.eururo.2011.06.034. Epub 2011 Jun 22. Eur Urol. 2012. PMID: 21715086 Free PMC article.

2

Hormone refractory prostate cancer: Management and advances.

Sonpavde G, Hutson TE, Berry WR. Sonpavde G, et al. Cancer Treat Rev. 2006 Apr;32(2):90-100. doi: 10.1016/j.ctrv.2005.12.005. Epub 2006 Feb 3. Cancer Treat Rev. 2006. PMID: 16458434 Review.

3

Systemic chemotherapy for urothelial cancer.

Sonpavde G, Hutson TE, Berry WR. Sonpavde G, et al. Clin Genitourin Cancer. 2006 Jun;5(1):34-42. doi: 10.3816/CGC.2006.n.015. Clin Genitourin Cancer. 2006. PMID: 16859577 Review.

4

Problems with the randomized discontinuation design.

Sonpavde G, Hutson TE, Galsky MD, Berry WR. Sonpavde G, et al. J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. doi: 10.1200/JCO.2006.08.1026. J Clin Oncol. 2006. PMID: 17008711 No abstract available.

5

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, Kadmon D. Sonpavde G, et al. Cancer. 2007 Dec 15;110(12):2628-39. doi: 10.1002/cncr.23085. Cancer. 2007. PMID: 17941029 Free article. Review.

6

Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.

Sonpavde G, Aparicio A, Guttierez I, Boehm KA, Hutson TE, Berry WR, Asmar L, von Hoff DD. Sonpavde G, et al. Clin Genitourin Cancer. 2007 Dec;5(7):457-9. doi: 10.3816/CGC.2007.n.036. Clin Genitourin Cancer. 2007. PMID: 18272030 Clinical Trial.

7

Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.

Sonpavde G, Hutson TE, Berry WR, Boehm KA, Asmar L. Sonpavde G, et al. Clin Genitourin Cancer. 2008 Sep;6(2):134-7. doi: 10.3816/CGC.2008.n.023. Clin Genitourin Cancer. 2008. PMID: 18824440 Clinical Trial.

8

Ketoconazole retains activity in patients with docetaxel-refractory prostate cancer.

Galsky MD, Simon K, Sonpavde G, Hutson TE, Fleming M, Kondagunta GV, Berry W. Galsky MD, et al. Among authors: sonpavde g. Ann Oncol. 2009 May;20(5):965-6. doi: 10.1093/annonc/mdp199. Ann Oncol. 2009. PMID: 19403937 Free article. No abstract available.

9

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.

Sonpavde G, Periman PO, Bernold D, Weckstein D, Fleming MT, Galsky MD, Berry WR, Zhan F, Boehm KA, Asmar L, Hutson TE. Sonpavde G, et al. Ann Oncol. 2010 Feb;21(2):319-324. doi: 10.1093/annonc/mdp323. Epub 2009 Jul 24. Ann Oncol. 2010. PMID: 19633050 Free article. Clinical Trial.

10

Satraplatin for the therapy of castration-resistant prostate cancer.

Sonpavde G, Sternberg CN. Sonpavde G, et al. Future Oncol. 2009 Sep;5(7):931-40. doi: 10.2217/fon.09.84. Future Oncol. 2009. PMID: 19792961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters